SciSight Ecosystem
WoS ESCI Q2Scopus Q2SCImago #4,947CAS 4区Gold OA

Cancer Treatment and Research Communications

Country: United Kingdom•WoS SCIE Quartile: Q2•Scopus SJR: 0.995•SCImago Rank: #4,947•Identifier (ISSN):2468-2942(Print)•Articles / Year: 320•Estimated Publication Fee (APC): $3,188 USD
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q2
3.5
↑ +1.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
35

35 papers with at least that number of citations each

WoS: ESCIQ2
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
320articles/year
100% Gold OA•0% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 3.5)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.75đ
WoS Q2 có IF ≥ 2.0(IF: 3.5)
🔵 Computed
20251.75đ
WoS Q2 có IF ≥ 2.0(IF: 2.4)
🔵 Computed
20231.50đ
WoS Q2(IF: 0)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.

Topics Covered (Recognized by AI)
Medicine98.7%Biology96.5%Internal medicine95.4%Genetics90.9%Cancer76.7%Pathology69.7%Oncology62.9%Surgery55.8%Chemistry43.9%Biochemistry38.6%Radiology30%Chemotherapy27.2%Immunology26.7%Cancer research26.5%Mathematics26%Lung cancer23.3%Gene21.9%Statistics21.2%Breast cancer20.4%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,947Scopus Q2SCImago Profile
Scopus Coverage:2016-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.995

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
35

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
3.49

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,188 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,289
3-Year Documents357
Citable Documents356

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ2
OncologyQ2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
Elsevier
Publication Language
English
Frequency
Periodic
Indexing & Databases
ScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRESCI
142/333Q2
ONCOLOGY
JCIESCI
167/333Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

11 year
YearImpact FactorArticles / YearTotal Citations
2026—35555
20252.4210260
2024—81507
20230102759
2022—1671,861
2021—1973,003
2020—1342,022
2019—30551
2018—26244
2017—34251
2016—36272
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Cancer Treatment and Research Communications

WoS Q2
0123202320252.40
Annual Impact Factor Metric
2025:2.4

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f6680cb6-211e-47b9-82e8-ec67faae52e9
Database Updated: 2026-10-01